Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: Cannabis

Terra Tech Corp. CEO, Derek Peterson, Discusses Recent News and Provides an Outlook for the Company in a New Audio Interview at

AUSTIN, Texas, April 20, 2017 (GLOBE NEWSWIRE) —, Inc. (SCV) and Terra Tech Corp. (OTC QX:TRTC) (“Terra Tech”) or (the “Company”), a vertically integrated cannabis-focused agriculture company, announced today that a new audio interview with the Company is now available. The interview can be heard at

Derek Peterson, CEO of Terra Tech, called in to to go over the exciting news for Terra Tech Corp. Topics covered in the interview include the recent White House comments on the cannabis industry, market penetration in California, the overwhelming successes in Nevada, the steady growth for Edible Gardens and more.

In the interview, regarding the current administration’s stance on cannabis, Peterson stated, “If we were having this conversation two years ago it wouldn’t be what it is today, but last November we had eight of the nine pieces of national legislation go through. That shows overwhelming support for an expanded …

Continue Reading

Posted in Client News| Tagged , , , |

4-12-17 SmallCapVoice Interview with Terra Tech Corp (TRTC)

Terra Tech Corp (TRTC)

Terra Tech Corp. CEO, Derek Peterson, called in to, Inc. to share his thoughts on the new White House administration’s stance on medical and recreational marijuana, the ramping up of TRTC’s efforts in Nevada, and the explosive growth the Company has had in the California market to date. Peterson also talked about their subsidiary Edible Gardens. Edible Gardens continues to provide meaningful revenues and steady cash flow adding over 100 new retailers in 2016.

Terra Tech Corp. (TRTC) operates through multiple subsidiary businesses including: Blüm, IVXX Inc., Edible Garden, MediFarm LLC and GrowOp Technology. Blüm’s retail medical cannabis facilities focus on providing the highest quality medical cannabis to patients who are looking for alternative treatments for their chronic medical conditions. Blüm offers a broad selection of medical cannabis products including; flowers, concentrates and edibles through its Oakland, CA and multiple Nevada locations. IVXX, Inc. is a wholly-owned subsidiary …

Continue Reading

Posted in Interviews| Tagged , , |

AXIM Biotechnologies, Inc. and API Develop Marinol Alternative

AXIM Biotechnologies, Inc.

Medical marijuana has presented life-changing treatment options for patients around the world, but with strict laws in many regions preventing the use of such pharmaceutical alternatives, progress has been gradual. There is still significant stigma surrounding the effects of medical marijuana and its use in a clinical treatment setting. Despite the many positive studies associated with these products, opposition persists in many sectors of the market. Companies such as AXIM Biotechnologies, Inc. (OTCQX: AXIM) have long been at the forefront of medical marijuana research and development, facing opposition from lobbyists and other detractors who seek to keep the status quo within the pharmaceutical industry. Until recently, Insys Therapeutics was one of those companies.

In the past, Insys Therapeutics has been active in the opposition of general marijuana legalization, donating $500,000 to a group called Arizonans for Responsible Drug Policy in the summer of 2016. The group launched a campaign …

Continue Reading

Posted in Articles| Tagged , , , |

Advantis Corporation CEO, Chris Swartz, Discusses Current Events and Recent News in a New Interview at

AUSTIN, Texas, March 31, 2017 (GLOBE NEWSWIRE) —, Inc. (SCV) and Advantis Corporation (Pink Sheets: ADVT) today announced that the Company’s CEO, Christopher Swartz, is featured in an audio interview at The interview outlining the recent news and future plans is now available and can be heard at

Christopher Swartz called in to to go over the Company’s progress in 2016, new product offerings, the recent news, and to answer a handful of shareholder questions that were submitted for this interview.

“2017 will be a banner year for the cannabis industry and we will be at the forefront,” Advantis CEO, Christopher Swartz said. is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well …

Continue Reading

Posted in Client News| Tagged , |

Bioequivalent Product to Marinol in the Works with AXIM Biotech at the Helm

AXIM Biotechnologies

In recent months, the medical benefits of cannabis have been all over the news. With reports that cannabis oil can reduce and even stop seizures, help patients with memory loss like dementia and Alzheimer’s, and even help to reduce pain associated with chronic illness, it makes sense that more and more biotech companies would be looking to get in on the market.

Earlier this week biotech newcomer AXIM Biotechnologies, Inc. (OTCQX: AXIM) announced that they would be teaming up with a United States based API (Active Pharmaceutical Ingredient) production company to further their production and creation of a dronabinol based functional chewing gum. AXIM is a forerunner in cannabinoid research and have been working for years to help develop solutions like Marinol, a gel capsule containing cannabinoid to help with things like nausea associated with AIDS treatment and chemotherapy.

About AXIM

AXIM has long been part of the cannabinoid …

Continue Reading

Posted in Articles| Tagged , , | Announces Investment in Breakwater MB, LLC a Cannabis-Focused Investment and Consulting Company

SAN GABRIEL, California, March 30, 2017 /PRNewswire/ — (OTCQB: CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors, today announces its investment in Breakwater MB, LLC, a cannabis-focused investment and consulting company. Building on the success that CIIX enjoyed through its investment in early-stage firm Medicine Man Technologies, the Company is pleased to announce another strategic investment in the cannabis industry.  

Breakwater MB was formed by CIIX board member and former CFO Paul Dickman as a means to invest capital in and provide consulting services to private, cannabis-focused companies as they transition into the public market. The invested capital will primarily be used to cover the costs of becoming a publicly traded company, a strategy CIIX expects will provide significant investment appreciation and opportunity for liquidity. All opportunities will be evaluated by the investment committee comprised of CIIX CEO Warren Wang, Medicine Man Technologies …

Continue Reading

Posted in Client News| Tagged , |